CSL Behring Will Discontinue Carimune NF in Third Quarter 2018
Discontinuation of the product is due to the preference among healthcare professionals and patients for newer, more advanced immune globulin options.
VONVENDI Approved to Treat Von Willebrand Disease
The U.S. Food and Drug Administration has approved Shire’s VONVENDI, a recombinant von Willebrand factor treatment for perioperative management of bleeding in adults 18 years and older with von Willebrand disease.
Study Finds Antibiotics Can Weaken the Immune System
Researchers have found antibiotics can be counterproductive and weaken the immune system’s ability to fight off bacteria.
Gene Therapy for Hemophilia: Edging Closer to Reality
Potentially curative gene therapy is in the works for hemophilia.
Replacement Therapy for Hereditary Angioedema: Innovations Define a New Standard of Care
Hereditary angioedema is a rare genetic disease for which replacement therapy provides safe and highly effective treatment.
Expanding Uses of IVIG
Researchers are taking a closer look at intravenous immune globulin for its potential to stop the progression of multiple complex conditions from lupus to multiple sclerosis.
Co-Administration of Albumin with Lactulose Reverses Hepatic Encephalopathy and Reduces Mortality in Liver Cirrhosis
A multidisciplinary team of investigators based in New Delhi randomized 120 patients with liver cirrhosis and overt hepatic encephalopathy (HE) to receive oral lactulose therapy or oral lactulose plus 1.5 g/kg/day of human albumin. The primary study endpoint was complete reversal of HE; secondary endpoints included mortality and length of hospital stay.
IVIG Highly Protective in Ferrets After Challenge with Severe Pandemic pH1N1 and Avian H5N1 Influenza Strains
Australian investigators tested the ability of intravenous immune globulin to protect against potential pandemic influenza virus in outbred ferrets, which are naturally susceptible to human influenza viruses and considered a relevant small animal model of human influenza infection.
Fibrin Sealants: When More Is Needed to Stop the Bleeding
Many years after the first products were introduced in the late 1990s, the need for fibrin sealants continues to increase.
Superbug Apocalypse: A Post-Antibiotic Era?
Antibiotics are the most commonly prescribed drugs worldwide. But now, widespread antimicrobial resistance caused by environments, hosts and overmedication may soon be the demise of these “wonder drugs.”
